JFL Life Sciences Limited (NSE:JFLLIFE)
12.00
+0.55 (4.80%)
At close: Feb 10, 2026
JFL Life Sciences Market Cap
JFL Life Sciences has a market cap or net worth of 395.94 million as of February 13, 2026. Its market cap has decreased by -40.25% in one year.
Market Cap
395.94M
Enterprise Value
486.07M
Revenue
744.78M
Ranking
n/a
PE Ratio
14.98
Stock Price
12.00
Market Cap Chart
Since September 8, 2022, JFL Life Sciences's market cap has decreased from 731.40M to 395.94M, a decrease of -45.86%. That is a compound annual growth rate of -16.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 395.94M | -4.00% |
| Dec 31, 2025 | 412.44M | -59.35% |
| Dec 30, 2024 | 1.01B | 122.29% |
| Dec 29, 2023 | 456.44M | 22.06% |
| Dec 30, 2022 | 373.95M | -48.87% |
| Sep 8, 2022 | 731.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vilin Bio Med | 453.38M |
| Vista Pharmaceuticals | 448.10M |
| Murae Organisor | 446.15M |
| Welcure Drugs and Pharmaceuticals | 444.94M |
| Panjon | 428.43M |
| Walpar Nutritions | 427.27M |
| ANG Lifesciences India | 342.65M |
| Sandu Pharmaceuticals | 338.62M |